lifestyle.sourcefed.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AEON Biopharma Inc
AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards
April 3, 2026
AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program
March 31, 2026
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
March 25, 2026
AEON Biopharma Appoints John Bencich as Chief Financial Officer
March 9, 2026
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting
March 5, 2026
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
January 21, 2026